This discrepancy between these results and ours could reflect differences in the disease stage being modeled, with exogenous Aβ application representing early-stage processes, while our 9-month-old APP/PS1 mice reflect a later stage of AD pathology. The gene discussed is APP; the disease is Alzheimer disease.